#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loss of consciousness Carcinoid syndrome Primitive neuroectodermal tumour Chronic inflammatory demyelinating polyradiculoneuropathy Undifferentiated sarcoma Malignant fibrous histiocytoma Iron overload Myeloid leukaemia Hormone-dependent prostate cancer Burkitt's lymphoma Skin cancer Idiopathic pulmonary fibrosis Autologous haematopoietic stem cell transplant Marginal zone lymphoma Mitochondrial myopathy More trials…

    Learn about Rare Diseases

    Sarcoidosis – Diagnostics Rhabdomyosarcoma – Trials in Disease Osteosarcoma recurrent Glycogen storage disease type I – Trials in Disease Synovial sarcoma Skin angiosarcoma – Diagnostics Factor IX deficiency Synovial sarcoma metastatic – Treatment MELAS syndrome – Diagnostics Malignant fibrous histiocytoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propafenone Hydrochloride Gsk3915393 Anhydrous Cyclophosphamide Axicabtagene Ciloleucel ANTIMETABOLITES Lamotrigine Golodirsen PETHIDINE HYDROCHLORIDE Livmoniplimab Bemcentinib Boserolimab Resiquimod Sulfate Linerixibat Crgd-Zw800-1 Nepafenac Benztropine Mesylate Venlafaxine Hydrochloride VOTOPLAM Minocycline Hydrochloride Hu5F9‐G4 More therapies…

    Learn about Your Condition

    Acute leukaemia Endocarditis enterococcal Glomerulonephritis membranous Bipolar I disorder Pneumonia Proteus syndrome Anxiety Leiomyosarcoma metastatic Psychotic behaviour Lennox-Gastaut syndrome Turner's syndrome Abdominal infection White matter lesion Spinal osteoarthritis Juvenile spondyloarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Shortened Treatment with Apalutamide and Enzalutamide for Patients with Low-Volume Metastatic Castration-Sensitive Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Leuprorelin
    • Triptorelin
    • Apalutamide
    The Netherlands

  • Study on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Aldesleukin
    • Lifileucel
    • Mesna
    Belgium Czechia Finland France Germany Greece +6

  • Study on Ciclosporin for Treating Atopic Keratoconjunctivitis in Adults

    Recruiting

    2 1 1
    Investigated Diseases:
    • Atopic keratoconjunctivitis
    Investigated Drugs:
    • Ciclosporin
    Denmark

  • Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on Melatonin and Light Therapy for Adults with Idiopathic Hypersomnia

    Recruiting

    2 1
    Investigated Diseases:
    • Hypersomnia
    Investigated Drugs:
    • Melatonin
    France

  • Study on Baclofen for Inpatient Detoxification in Patients with GHB Use Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Baclofen
    • Sodium Oxybate
    The Netherlands
Previous Page
1 … 559 560 561 562 563 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!